Efficacy and Safety of Triazavirin Therapy for Coronavirus Disease 2019: A Pilot Randomized Controlled Trial
Xiaoke Wu(China Academy of Chinese Medical Sciences), Baofeng Yang(Harbin Medical University), Kaijiang Yu(Brigham and Women's Hospital), Jingshu Gao(First Affiliated Hospital of Heilongjiang University of Chinese Medicine), Huichao Qin(First Affiliated Hospital of Heilongjiang University of Chinese Medicine), Lu Li(Tsinghua University), Benzhi Cai(Harbin Medical University), Ben W. Mol(University of Aberdeen), Wenjie Wang(Harbin Medical University), Yue Li(Emory University), Min Zhang(Heilongjiang Provincial Hospital), Yu Wang(Hangzhou Hospital of Traditional Chinese Medicine), Kang Li(Harbin Medical University), Yong Zhang(Eisai (Japan)), Xiaoli Hu(Shandong Eye Hospital), Xia Wu(First Affiliated Hospital of Heilongjiang University of Chinese Medicine), Yongchen Wang(Harbin Medical University), Mingyan Zhao(Harbin Medical University), Zhimin Du(Shanxi University), Lìyǐng Zhū(Fourth Affiliated Hospital of Harbin Medical University), Wanhai Xu(Harbin Medical University), Hongli Ma(Chinese Academy of Medical Sciences & Peking Union Medical College), Yan Hou(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 59
Related Papers
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
|Alzheimer s Research & Therapy|2021|818
Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence
|BMJ|2012|794
Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis
|Cell Death and Disease|2018|601
Cognitive, motor, behavioural and academic performances of children born preterm: a meta‐analysis and systematic review involving 64 061 children
|BJOG An International Journal of Obstetrics & Gynaecology|2017|545
Etiological and epidemiological features of acute respiratory infections in China
|Nature Communications|2021|530